Mapping of 5‐HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies
暂无分享,去创建一个
J. Palacios | G. Mengod | M. Vilaró | J F López-Giménez | J M Palacios | G Mengod | M T Vilaró | J. López-Giménez
[1] J. Leysen,et al. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. , 1981, Life sciences.
[2] C. Katona,et al. Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment , 1994, Brain Research.
[3] G. Aghajanian,et al. Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist. , 1994, European journal of pharmacology.
[4] Trevor Sharp,et al. A review of central 5-HT receptors and their function , 1999, Neuropharmacology.
[5] M. Mikuni,et al. Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration , 2000, Brain Research.
[6] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors , 1985, Brain Research.
[7] P S Goldman-Rakic,et al. Quantitative autoradiographic mapping of serotonin 5‐HT1 and 5‐HT2 receptors and uptake sites in the neocortex of the rhesus monkey , 1989, The Journal of comparative neurology.
[8] J. Wettstein,et al. Selectivity of action of typical and atypical antipsychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[9] M. Nöthen,et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene , 1996, The Lancet.
[10] J. Palacios,et al. Human striosomes are enriched in 5‐HT2A receptors: autoradiographical visualization with [3H]MDL100,907, [125I](±)DOI and [3H]ketanserin , 1999, The European journal of neuroscience.
[11] J. Palacios,et al. Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.
[12] H. Meltzer,et al. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens. , 1998, European journal of pharmacology.
[13] J. Kehne,et al. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. , 1993, The Journal of pharmacology and experimental therapeutics.
[14] H. Ladinsky,et al. Comparative anatomical distribution of serotonin 1A, 1Dα and 2A receptor mRNAs in human brain postmorten , 1996 .
[15] F. Blaney,et al. 5-HT2 receptor subtypes: a family re-united? , 1995, Trends in pharmacological sciences.
[16] B. McEwen,et al. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.
[17] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[18] C. J. Schmidt,et al. Blockade of Striatal 5‐Hydroxytryptmine2 Receptors Reduces the Increase in Extracellullar Concentrations of Dopamine Produced by the Amphhetamine analogue 3,4‐Methylenedioxymethamphetamine , 1994, Journal of neurochemistry.
[19] J. Kehne,et al. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. , 1996, The Journal of pharmacology and experimental therapeutics.
[20] D. Morilak,et al. Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain , 1993, Neuroscience.
[21] M. Palkovits,et al. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala , 1993, Brain Research.
[22] P. Goldman-Rakic,et al. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[23] S. Snyder,et al. Neurotransmitter receptors in frontal cortex of schizophrenics. , 1979, Archives of general psychiatry.
[24] Paul J. Harrison,et al. The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain , 1995, Brain Research.
[25] M. Molliver,et al. Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex , 1988, Brain Research.
[26] B. Mulsant,et al. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. , 1999, The American journal of psychiatry.
[27] D. Wright,et al. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain , 1995, The Journal of comparative neurology.
[28] L. Descarries,et al. Cellular and subcellular distribution of the serotonin 5‐HT2A receptor in the central nervous system of adult rat , 1999, The Journal of comparative neurology.
[29] M. Pompeiano,et al. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.
[30] H. Meltzer. The Role of Serotonin in Antipsychotic Drug Action , 1999, Neuropsychopharmacology.
[31] P S Goldman-Rakic,et al. Quantitative autoradiography of major neurotransmitter receptors in the monkey striate and extrastriate cortex , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] M. Karnovsky,et al. A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES , 1964, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[33] G. Aghajanian,et al. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release , 1999, Brain Research.
[34] L. JakabR,et al. 霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位 , 1998 .
[35] M. Lidow,et al. Adrenergic and serotonergic receptors in aged monkey neocortex , 1995, Neurobiology of Aging.
[36] Paul J. Harrison,et al. 5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia , 1996, Neuropsychopharmacology.
[37] R. Schreiber,et al. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. , 1995, The Journal of pharmacology and experimental therapeutics.
[38] H. Ladinsky,et al. Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain postmortem. , 1996, Brain Research. Molecular Brain Research.
[39] D. Geschwind,et al. Distribution of major neurotransmitter receptors in the motor and somatosensory cortex of the rhesus monkey , 1989, Neuroscience.
[40] J. Kehne,et al. The role of 5-HT2A receptors in antipsychotic activity. , 1995, Life sciences.
[41] C. J. Schmidt,et al. 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. , 1992, European journal of pharmacology.
[42] V. Arango,et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.
[43] A. Ravindran,et al. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. , 2000, American journal of medical genetics.
[44] K. Lesch,et al. Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter , 1999, Neuroscience Letters.
[45] C. Halldin,et al. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[46] J D Brodie,et al. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[47] M. Pompeiano,et al. Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites , 1990, Brain Research.
[48] L. Iversen,et al. Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type , 1984, Neuroscience Letters.
[49] B. Dean,et al. Decreased frontal cortical serotonin2A receptors in schizophrenia , 1996, Schizophrenia Research.
[50] J. Palacios,et al. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907 , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[51] H. Yoneda,et al. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. , 1996, American journal of medical genetics.
[52] S. Hamada,et al. Localization of 5-HT2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken. , 1998, Brain research. Molecular brain research.
[53] C. J. Schmidt,et al. Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade. , 1996, The Journal of pharmacology and experimental therapeutics.
[54] C. J. Schmidt,et al. The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. , 1995, European journal of pharmacology.
[55] B. Dean,et al. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain , 1995, Behavioural Brain Research.
[56] F. Fonnum,et al. Topography of cholinergic and substance P pathways in the habenulo-interpeduncular system of the rat. An immunocytochemical and microchemical approach , 1987, Neuroscience.
[57] C. Bethea,et al. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. , 1999, Brain research. Molecular brain research.
[58] R. Pearson,et al. The Human Nervous System. Basic Elements of Structure and Function , 1967, The Yale Journal of Biology and Medicine.
[59] Anat Biegon,et al. Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide , 1990, Brain Research.
[60] P S Goldman-Rakic,et al. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Palacios,et al. [3H]MDL100,907 labels 5-HT2A serotonin receptors selectively in primate brain , 1998, Neuropharmacology.
[62] G. Aghajanian,et al. Serotonin Induces Excitatory Postsynaptic Potentials in Apical Dendrites of Neocortical Pyramidal Cells , 1997, Neuropharmacology.
[63] R. Schreiber,et al. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. , 1994, European journal of pharmacology.
[64] D. Graham,et al. 5HT2 receptors in dementia of the Alzheimer type: A quantitative autoradiographic study of frontal cortex and hippocampus , 1990 .
[65] S H Snyder,et al. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.